Neurodegenerative Disease clinical trials at UC Irvine
2 in progress, 1 open to eligible people
PK, and PD Study of PGN-EDODM1 in Participants With Myotonic Dystrophy Type 1
open to eligible people ages 18-60
The primary purpose of the study is to evaluate the safety and tolerability of single intravenous (IV) doses of PGN-EDODM1 administered to participants with Myotonic Dystrophy Type 1 (DM1). The study consists of 2 periods: A Screening Period (up to 30 days) and a Treatment and Observation Period (16 weeks).
Irvine 5359777, California 5332921 and other locations
Continued Evaluation of Patients With Parkinson's Disease Who Previously Received BRT-DA01
Sorry, accepting new patients by invitation only
This is a multicenter study to evaluate the safety and clinical outcomes of BRT-DA01 in subjects with PD who previously received BRT-DA01 in the Phase 1 Study MSK-DA01-101.No investigational therapy will be administered in this study.
Orange 5379513, California 5332921 and other locations
Last updated: